By late 2025, Jensen Huang—chief executive officer of NVIDIA Corporation (NVIDIA), an American technology company headquartered in Santa Clara, California—faced a critical strategic decision. NVIDIA and Norma Inc. (Norma) collaborated to apply hybrid quantum computing with classical artificial intelligence to drug discovery using the NVIDIA CUDA-Q platform. Their work achieved a 73 times speed-up of quantum drug discovery and showed how quantum and classical computing could accelerate early-stage research. NVIDIA now faced a strategic decision about whether to deepen its partnership with Norma or continue independently as it sought leadership in quantum-enabled health care while balancing innovation, control, and sustainability concerns.
看看哪些人也有訂購？